Lundbeck fires the first shot in a bidding war with Alkermes over sleep biotech Avadelnews2025-11-14T12:10:08+00:00November 14th, 2025|Endpoints News|
Merck to buy Cidara and its preventive influenza biologic for $9.2Bnews2025-11-14T12:09:54+00:00November 14th, 2025|Endpoints News|
Mikael Dolsten removes himself from board candidacy at Novo; Bavarian Nordic chairman resignsnews2025-11-14T12:00:22+00:00November 14th, 2025|Endpoints News|
Medicxi, which backed Vicebio and Versanis, closes new €500M biotech fundnews2025-11-14T11:57:42+00:00November 14th, 2025|Endpoints News|
FDA approves Kura and Kyowa Kirin’s drug for form of acute myeloid leukemianews2025-11-13T19:58:31+00:00November 13th, 2025|Endpoints News|
Law to end government shutdown also seeks to accelerate prescription-to-OTC switchesnews2025-11-13T19:35:40+00:00November 13th, 2025|Endpoints News|
UK gives drugmakers third extension to opt out of medicine rebate schemenews2025-11-13T18:39:59+00:00November 13th, 2025|Endpoints News|
Pfizer closes up to $10B deal for obesity biotech Metseranews2025-11-13T17:51:38+00:00November 13th, 2025|Endpoints News|
Hims launches lab testing for preventive carenews2025-11-13T17:00:04+00:00November 13th, 2025|Endpoints News|
